The company is not selling any securities under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholder.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACXP:
- Acurx Pharmaceuticals’ Earnings Call: Progress Amidst Funding Challenges
- Acurx assumed with a Buy at H.C. Wainwright
- Acurx Pharmaceuticals: Promising Antibiotic Developments and Strong Financial Position Justify Buy Rating
- Acurx Pharmaceuticals Reports Improved Q1 2025 Results
- Acurx Pharmaceuticals Enters $12M Stock Purchase Agreement